In dermatology, prior authorizations (PAs) have become a common administrative tool that payers use to manage the utilization of biologics and other expensive therapies.1 PAs require physicians to obtain pretreatment approval from a patient’s insurer for the reimbursement of a specific drug or service. PAs are meant to control costs by preventing the inappropriate use of medical resources.
Rogers AT, Sutherland B, Loss MJ. Prior Authorizations for Diagnostic Skin Biopsies: Does Anyone Benefit? JAMA Dermatol. 2017;153(11):1091–1092. doi:10.1001/jamadermatol.2017.3516
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: